As elevation in ALOX15 or its metabolites has been associated with increased risk of atherogenesis, metabolic dysfunction–associated steatotic liver disease, diabetes, stroke, Alzheimer’s disease, and breast and prostate cancer, detailed rephenotyping was performed (10, 24–30). This evidence concerns the gene ALOX15 and liver disorder.